Natalia Kusak

Natalia Kusak

Auto-generated profile, based on publicly available information

Natalia Kusak

Students’ Research Group at the Department of Toxicology, Medical University of Lublin

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KBKinga Brzuszkiewicz
Kinga Brzuszkiewicz
GRGracjan Rudziński
Gracjan Rudziński
BŁBorys Łozowski
Borys Łozowski
PRPrzemysław Raczkiewicz
Przemysław Raczkiewicz
NKNatalia Kusak
Natalia Kusak
ESEwelina Soroka
Ewelina Soroka
Introduction: Schizophrenia is a psychotic disease characterized by multifaceted psychopathology. To date, research has shown that it is an inherited disease and significant progress has been made in identifying genetic risk factors. Methods: This paper summarizes the current and most recent findings on the role of environmental factors, and demonstrates the continued need for more in-depth research to better understand how this type of disorder occurs. Results: Recent studies show that 15-40% of the risk that comes from environmental sources is not fully understood. Environmental factors that have been repeatedly studied and have been proven to influence the development of the disease include: obstetric complications, infections, childbirth in the winter or spring month, living in the city, severe childhood events or marijuana use. Discussion: Schizophrenia is a devastating mental illness that remains poorly understood. A full picture of how genetic and environmental risk factors affect the risk of developing schizophrenia requires an understanding of the interactions between them. It should be taken into account that for this disorder, the interactions between genetic and environmental risk factors are also not well understood and deserve further research in the future. In the case of schizophrenia, the interactions between environmental and genetic risk factors are not well understood and still require further research. Elucidating the mechanisms underlying the disease is extremely important, as it may have an impact on taking measures to prevent the development of the disorder. In addition, their discovery will help improve treatment. In conclusion, it is important to emphasize the need for further research to better understand the impact of environmental factors on the development of susceptibility to a mental disorder such as schizophrenia.

18 May 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
APAldona Pażyra
Aldona Pażyra
PSPaweł Stanicki
Paweł Stanicki
JSJulita Szarpak
Julita Szarpak
NKNatalia Kusak
Natalia Kusak
NŻNatalia Żak
Natalia Żak
BJBarbara Jaworska
Barbara Jaworska
In 2019, according to WHO estimates, 262 million people were affected by asta, resulting in 455,000 deaths. Asthma, is a chronic inflammatory disease of the airways that causes reversible bronchoconstriction, making it difficult for patients to breathe. Exacerbations of the disease can be caused by a variety of factors but share similar symptoms such as wheezing, coughing, shortness of breath and chest tightness. Severe asthma exacerbations are defined as symptoms that do not respond to inhaled medications and improve only after oral or intravenous steroid administration. Asthma-related deaths often occur during exacerbations. Vitamin D, which is produced naturally in the body and found in some foods, is a steroid-derived vitamin. Adequate doses of this vitamin, administered through medication or supplements, can be used to maintain its proper levels in the organism. Vitamin D is essential for regulating calcium levels in the body and for bone remodeling. It also has immunomodulatory effects, affecting both innate and adaptive immunity. This partly explains its association with changes in the airway epithelium that occur as a result of inflammation in asthma. The study aims to summarize the current knowledge on the relationship of vitamin D with asthma symptom control. The present study is based on literature available in scientific databases from 2013-2016, such as PubMed, Corchane Library and Google Scholar, using the following keywords: "vitamin D" and "asthma." Vitamin D deficiency is prevalent in children and adults worldwide. A critical analysis of the literature reveals that the therapeutic administration of vitamin D has no apparent advantage in treating asthma, especially in children. Nevertheless, for adults with mild asthma, vitamin D supplementation shows promise for improved outcomes. However, there is a pressing need for large-scale clinical trials to determine the efficacy and safety of this therapeutic approach for both age groups.

21 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PSPaweł Stanicki
Paweł Stanicki
JSJulita Szarpak
Julita Szarpak
APAldona Pażyra
Aldona Pażyra
NKNatalia Kusak
Natalia Kusak
NŻNatalia Żak
Natalia Żak
BJBarbara Jaworska
Barbara Jaworska
INTRODUCTION AND PURPOSE: Long non-coding RNAs are key regulators of gene expression and tumorigenesis. Deleted in leukemia 1 (DLEU1) is significant in cancer development. This article reviews DLEU1's role across cancers, assessing its diagnostic and therapeutic potential. METHODS: A review of scientific articles from PubMed and Google Scholar was conducted. DESCRIPTION OF THE STATE OF KNOWLEDGE: DLEU1 drives tumor growth in glioblastoma, esophageal, colorectal, and oral cancers by interacting with key miRNAs and genes, promoting malignancy. In breast and ovarian cancers, DLEU1 modulates migration and invasion via specific pathways. In cervical cancer, DLEU1 is linked to immune modulation and serves as a prognostic marker. SUMMARY: DLEU1 is a vital regulator in various cancers, offering potential as a diagnostic and therapeutic target.

20 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NŻNatalia Żak
Natalia Żak
ABAleksandra Błaszczyk
Aleksandra Błaszczyk
APAldona Pażyra
Aldona Pażyra
NKNatalia Kusak
Natalia Kusak
BJBarbara Jaworska
Barbara Jaworska
PSPaweł Stanicki
Paweł Stanicki
Background: In 2020, the World Health Organization (WHO) estimated that 650 million adults worldwide are obese, and 2.8 billion individuals struggle with overweight. Obesity is associated with an increased risk of cardiovascular diseases, type 2 diabetes, heart disease, adverse effects on mental health, the development of certain cancers, and other conditions. In recent years, there has been growing interest in the role of melatonin, which has therapeutic potential in the treatment of obesity. Studies suggest that melatonin supplementation may lead to weight reduction and improvement in metabolic parameters, significantly reduce cardiovascular disease risk factors, and enhance insulin sensitivity in obese individuals. Aim of study: This review aims to present the latest scientific findings on the impact of melatonin supplementation on the development of obesity and its complications. We focus primarily on the mechanisms of melatonin's action in the context of obesity, particularly on potential pathways that have not yet been thoroughly explored. Our aim is to provide deeper insights into research on obesity and its prevention. Materials and Methods: Search was conducted using PubMed and Google Scholar databases, utilizing the keywords "obesity," "melatonin," and "weight loss" in various configurations. The review primarily considers studies published after 2016 that are available online. Summary Melatonin supplementation leads to a statistically significant reduction in blood glucose levels and an increase in cellular insulin sensitivity. Its promising properties in the treatment of obesity have been demonstrated through the reduction of oxidative stress, indicating a potential adjunct for weight loss. Based on the cited studies, the beneficial effects of melatonin supplementation on cardiovascular risk factors have been confirmed. Melatonin could be considered as an adjunctive therapy for obese individuals who do not respond to other treatment modalities.

21 November 2022 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KBKinga Brzuszkiewicz
Kinga Brzuszkiewicz
KPKinga Pożarowska
Kinga Pożarowska
GRGracjan Rudziński
Gracjan Rudziński
BŁBorys Łozowski
Borys Łozowski
NKNatalia Kusak
Natalia Kusak
MTMichał Tchórz
Michał Tchórz
During the autumn season, it is common for mushroom pickers to eat poisonous mushrooms. This is due to many reasons, including the ignorance of pickers. The most common is the misidentification of inedible species as edible mushrooms. The result is poisoning, which in many cases requires hospitalization. This paper presents a case report of toadstool poisoning by a 62-year-old female patient. In addition, other relevant publications on intoxication, diagnostic methods and treatment are reviewed. The purpose of this paper is to present the management and treatment of a case of toadstool poisoning. The effects of mushroom poisoning can range from mild disorders, mainly gastrointestinal to organ failure and even death. Significant elevations of liver enzymes and prothrombin time are important in laboratory tests in cases of intoxication. Treatment most often involves specific antidotes, such as Sylimarin, Acetylcysteine. The diagnosis in most cases is made on the basis of the clinical picture and a thorough interview with the patient, and the diagnosis is established by detecting toxins in a urine test. The prognosis is better if patients with toadstool poisoning are admitted to the hospital early. It is worth noting that gastrointestinal syndromes can also result from eating raw or inadequately cooked mushrooms, and by eating them excessively or too often. Proper diagnosis and treatment of mushroom poisoning can save lives. It is very important to raise public awareness of mushroom poisoning, as well as early detection of potential signs of intoxication. Cooperation with the poison center and mycologists is very important, especially in high-risk cases.

9 January 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MDMaciej Dobosz
Maciej Dobosz
GRGracjan Rudziński
Gracjan Rudziński
ZCZuzanna Chilimoniuk
Zuzanna Chilimoniuk
PWPiotr Więsyk
Piotr Więsyk
NKNatalia Kusak
Natalia Kusak
ACAleksandra Chałupnik
Aleksandra Chałupnik
Introduction and purpose: More and more reports suggest that diabetes plays an important role in the pathogenesis of Alzheimer's disease (AD). Understanding this link may provide a new approach to modulating the onset and progression of sporadic AD cases. The aim of the study is to present the current state of knowledge on the basic mechanisms and factors influencing the development of AD in patients with type 2 diabetes in the context of clinical practice. State of knowledge: It is estimated that up to 80% of Alzheimer's patients have glucose intolerance or diabetes. Impaired insulin signaling can lead to abnormal processing and accumulation of beta-amyloid protein, which can result in memory deficits and cognitive decline. Insulin deficiency can also cause over-activity of the GSK3 enzyme, leading to tau hyperphosphorylation and senile plaque accumulation. Diabetes can also cause fibrotic changes in cerebral vessels, disrupting brain metabolism and potentially leading to hippocampus atrophy. The release of cytokines during the metabolic syndrome can also cause oxidative stress and neuroinflammation, which may contribute to neuronal atrophy. It has been reported that healthy diet, physical exercises and prevention of metabolic diseases may reduce the incidence of AD. Conclusions: Epidemiological data and pathophysiological studies indicate a significant relationship between these diseases that AD is sometimes called Type 3 diabetes. Early detection of hyperglycemia and its proper management, may be crucial in the context of the clinical prevention of dementia diseases. It is essential to pay attention to the cognitive abilities of patients with metabolic diseases.